TrialDer Urologe. Ausg. A2007

[Immunotherapy of metastatic renal cell carcinoma with interleukin-2, interferon-alpha2a and erythropoietin-beta].

M Schenck et al.PubMed ↗Publisher ↗

No numbers read from the abstract.